Patents by Inventor Dennis G. Ballinger

Dennis G. Ballinger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Isolated oligonucleotide and use thereof in nucleic acid sequencing
    Patent number: 9890375
    Abstract: Provided are an isolated oligonucleotide and a use thereof in nucleic acid sequencing, wherein the isolated oligonucleotide comprises a first strand, wherein the 5?-end nucleotide of the first strand has a phosphate group, and the 3?-end nucleotide of the first strand is a dideoxynucleotide, and a second strand, wherein the 5?-end nucleotide of the second strand does not have a phosphate group, and the 3?-end nucleotide of the second strand is a dideoxynucleotide, wherein the first strand is longer than the second strand in length, and a double-stranded structure is formed between the first strand and the second strand.
    Type: Grant
    Filed: September 12, 2014
    Date of Patent: February 13, 2018
    Assignee: BGI SHENZHEN CO., LIMITED
    Inventors: Chunyu Geng, Dennis G. Ballinger, Yanyan Zhang, Shujin Fu, Lingyu He, Wenwei Zhang, Hui Jiang
  • Isolated oligonucleotide and use thereof in nucleic acid sequencing
    Publication number: 20170275609
    Abstract: Provided are an isolated oligonucleotide and a use thereof in nucleic acid sequencing, wherein the isolated oligonucleotide comprises a first strand, wherein the 5?-end nucleotide of the first strand has a phosphate group, and the 3?-end nucleotide of the first strand is a dideoxynucleotide, and a second strand, wherein the 5?-end nucleotide of the second strand does not have a phosphate group, and the 3?-end nucleotide of the second strand is a dideoxynucleotide, wherein the first strand is longer than the second strand in length, and a double-stranded structure is formed between the first strand and the second strand.
    Type: Application
    Filed: September 12, 2014
    Publication date: September 28, 2017
    Inventors: Chunyu Geng, Dennis G. Ballinger, Yanyan Zhang, Shujin Fu, Lingyu He, Wenwei Zhang, Hui Jiang
  • Growth factor antagonist materials and methods
    Patent number: 6706871
    Abstract: The present invention provides nucleic acids encoding Sprouty related human growth factor antagonist proteins (designated FGFAn-Hy), the polypeptides encoded by these nucleic acids and uses of these and related products.
    Type: Grant
    Filed: February 26, 2002
    Date of Patent: March 16, 2004
    Assignee: Nuvelo, Inc.
    Inventors: Dennis G. Ballinger, Julie Reeder Montgomery
  • Novel angiopoietin materials and methods
    Publication number: 20030228659
    Abstract: The present invention provides novel nucleic acids encoding human angiopoietins, the novel polypeptides encoded by these nucleic acids and uses of these and related products.
    Type: Application
    Filed: January 24, 2003
    Publication date: December 11, 2003
    Inventors: Dennis G. Ballinger, Julie Reeder Montgomery
  • Stem cell maintenance factor materials and methods
    Publication number: 20030027255
    Abstract: The present invention provides novel nucleic acids encoding human stem cell maintenance factors, the novel polypeptides encoded by these nucleic acids and uses of these and related products.
    Type: Application
    Filed: October 26, 2001
    Publication date: February 6, 2003
    Inventors: Dennis G. Ballinger, Radoje T. Drmanac, Ivan Labat, Birgit Stache-Crain, Mark C. Dickson, Lee W. Jones, Aidong Xue, Y. Tom Tang, Chenghua Liu, Vinod Asundi
  • Growth factor antagonist materials and methods
    Patent number: 6485920
    Abstract: The present invention provides nucleic acids encoding Sprouty related human growth factor antagonist proteins (designated FGFAn-Hy), the polypeptides encoded by these nucleic acids and uses of these and related products.
    Type: Grant
    Filed: March 4, 2002
    Date of Patent: November 26, 2002
    Assignee: Hyseq Inc.
    Inventors: Dennis G. Ballinger, Julie Reeder Montgomery
  • Materials and methods relating to lipid metabolism
    Publication number: 20020142953
    Abstract: The present invention provides novel nucleic acids encoding human apolipoproteins, lipases, and lipoprotein receptor proteins; the novel polypeptides encoded by these nucleic acids; and uses of these and related products.
    Type: Application
    Filed: April 16, 2001
    Publication date: October 3, 2002
    Inventors: Dennis G. Ballinger, Deborah Loeb, Julie R. Montgomery, Y. Tom Tang, Ping Zhou, Ryle Goodrich, Chenghua Liu, Vinod Asundi, Qing A. Zhao, Tom Wehrman, Radoje T. Drmanac, Feiyan Ren, Xiaohong B. Qian, Dunrui Wang
  • Sprouty related growth factor antagonist (FGFAn-Hy) materials and methods
    Patent number: 6423682
    Abstract: The present invention provides nucleic acids encoding Sprouty related human growth factor antagonist proteins (designated FGFAn-Hy), the polypeptides encoded by these nucleic acids and uses of these and related products.
    Type: Grant
    Filed: August 6, 1999
    Date of Patent: July 23, 2002
    Assignee: HYSEQ, Inc.
    Inventors: Dennis G. Ballinger, Julie Reeder Montgomery
  • Interleukin—1 Hy2 materials and methods
    Patent number: 6372892
    Abstract: The present invention provides novel nucleic acids encoding IL-1 Hy2, a novel member of the Interleukin-1 Receptor Antagonist family, the novel polypeptides encoded by these nucleic acids and uses of these and related products.
    Type: Grant
    Filed: March 10, 2000
    Date of Patent: April 16, 2002
    Assignee: Hyseq, Inc.
    Inventors: Dennis G. Ballinger, Ann M. Pace, Hai Shan Lin
  • Polynucleotides encoding IL-1 Hy2 polypeptides
    Patent number: 6365726
    Abstract: The present invention provides novel nucleic acids encoding IL-1 Hy2, a novel member of the Interleukin-1 Receptor Antagonist family, the novel polypeptides encoded by these nucleic acids and uses of these and related products.
    Type: Grant
    Filed: May 22, 2000
    Date of Patent: April 2, 2002
    Assignee: Hyseq, Inc.
    Inventors: Dennis G. Ballinger, John Ford, Alice Suk-Yue Ho, Hai Shan Lin, Ann M. Pace
  • Interleukin-1 Hy2 materials and methods
    Patent number: 6339141
    Abstract: The present invention provides novel nucleic acids encoding IL-1 Hy2, a novel member of the Interleukin-1 Receptor Antagonist family, the novel polypeptides encoded by these nucleic acids and uses of these and related products.
    Type: Grant
    Filed: May 20, 1999
    Date of Patent: January 15, 2002
    Assignee: Hycey Inc.
    Inventors: Dennis G. Ballinger, Ann M. Pace
  • Chromosome 11-linked coronary heart disease susceptibility gene CHD1
    Patent number: 6225451
    Abstract: Human coronary heart disease susceptibility gene (CHD1), some alleles of which are related to susceptibility to coronary heart disease. Germline mutations in the CHD1 gene and their use in the diagnosis of predisposition to coronary heart disease and to metabolic disorders, including hypoalphalipoproteinemia, familial combined hyperlipidemia, insulin resistant syndrome X or multiple metabolic disorder, obesity, diabetes and dyslipidemic hypertension. Presymptomatic therapy of individuals who carry deleterious alleles of the CHD1 gene (including gene therapy, protein replacement therapy, and administration of protein mimetics and inhibitors). The screening of drugs for dyslipidemic therapy.
    Type: Grant
    Filed: March 4, 1999
    Date of Patent: May 1, 2001
    Assignee: Myriad Genetics, Inc.
    Inventors: Dennis G. Ballinger, Wei Ding, Susanne Wagner, Mark A. Hess